331 related articles for article (PubMed ID: 25908244)
1. The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence.
Montes M; Nielsen MM; Maglieri G; Jacobsen A; Højfeldt J; Agrawal-Singh S; Hansen K; Helin K; van de Werken HJG; Pedersen JS; Lund AH
Nat Commun; 2015 Apr; 6():6967. PubMed ID: 25908244
[TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype.
Montes M; Lubas M; Arendrup FS; Mentz B; Rohatgi N; Tumas S; Harder LM; Skanderup AJ; Andersen JS; Lund AH
Nat Commun; 2021 Apr; 12(1):2459. PubMed ID: 33911076
[TBL] [Abstract][Full Text] [Related]
3. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
4. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
[TBL] [Abstract][Full Text] [Related]
5. Senescence-Like Phenotypes in Human Nevi.
Joselow A; Lynn D; Terzian T; Box NF
Methods Mol Biol; 2017; 1534():175-184. PubMed ID: 27812879
[TBL] [Abstract][Full Text] [Related]
6. FOXA1 mediates p16(INK4a) activation during cellular senescence.
Li Q; Zhang Y; Fu J; Han L; Xue L; Lv C; Wang P; Li G; Tong T
EMBO J; 2013 Mar; 32(6):858-73. PubMed ID: 23443045
[TBL] [Abstract][Full Text] [Related]
7. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence.
Agger K; Cloos PA; Rudkjaer L; Williams K; Andersen G; Christensen J; Helin K
Genes Dev; 2009 May; 23(10):1171-6. PubMed ID: 19451217
[TBL] [Abstract][Full Text] [Related]
8. MZF1 mediates oncogene-induced senescence by promoting the transcription of p16
Wu D; Tan H; Su W; Cheng D; Wang G; Wang J; Ma DA; Dong GM; Sun P
Oncogene; 2022 Jan; 41(3):414-426. PubMed ID: 34773072
[TBL] [Abstract][Full Text] [Related]
9. p16INK4a-induced senescence is disabled by melanoma-associated mutations.
Haferkamp S; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging Cell; 2008 Oct; 7(5):733-45. PubMed ID: 18843795
[TBL] [Abstract][Full Text] [Related]
10. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
[TBL] [Abstract][Full Text] [Related]
11. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus.
Dietrich N; Bracken AP; Trinh E; Schjerling CK; Koseki H; Rappsilber J; Helin K; Hansen KH
EMBO J; 2007 Mar; 26(6):1637-48. PubMed ID: 17332741
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.
Li H; Wang W; Liu X; Paulson KE; Yee AS; Zhang X
Oncogene; 2010 Sep; 29(36):5083-94. PubMed ID: 20581871
[TBL] [Abstract][Full Text] [Related]
13. Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation.
Martin N; Popov N; Aguilo F; O'Loghlen A; Raguz S; Snijders AP; Dharmalingam G; Li S; Thymiakou E; Carroll T; Zeisig BB; So CW; Peters G; Episkopou V; Walsh MJ; Gil J
EMBO J; 2013 Apr; 32(7):982-95. PubMed ID: 23455154
[TBL] [Abstract][Full Text] [Related]
14. Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.
Haferkamp S; Scurr LL; Becker TM; Frausto M; Kefford RF; Rizos H
J Invest Dermatol; 2009 Aug; 129(8):1983-91. PubMed ID: 19212341
[TBL] [Abstract][Full Text] [Related]
15. BRAFE600-associated senescence-like cell cycle arrest of human naevi.
Michaloglou C; Vredeveld LC; Soengas MS; Denoyelle C; Kuilman T; van der Horst CM; Majoor DM; Shay JW; Mooi WJ; Peeper DS
Nature; 2005 Aug; 436(7051):720-4. PubMed ID: 16079850
[TBL] [Abstract][Full Text] [Related]
16. p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.
Gallagher SJ; Thompson JF; Indsto J; Scurr LL; Lett M; Gao BF; Dunleavey R; Mann GJ; Kefford RF; Rizos H
Neoplasia; 2008 Nov; 10(11):1231-9. PubMed ID: 18953432
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p16
Khatiwala RV; Zhang S; Li X; Devejian N; Bennett E; Cai C
Stem Cell Rev Rep; 2018 Aug; 14(4):612-625. PubMed ID: 29675777
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Regulation of the p16 Tumor Suppressor Gene.
Kotake Y; Naemura M; Murasaki C; Inoue Y; Okamoto H
Anticancer Res; 2015 Aug; 35(8):4397-401. PubMed ID: 26168478
[TBL] [Abstract][Full Text] [Related]
19. Cells exhibiting strong
Liu JY; Souroullas GP; Diekman BO; Krishnamurthy J; Hall BM; Sorrentino JA; Parker JS; Sessions GA; Gudkov AV; Sharpless NE
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2603-2611. PubMed ID: 30683717
[TBL] [Abstract][Full Text] [Related]
20. Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation.
Houben R; Ortmann S; Drasche A; Troppmair J; Herold MJ; Becker JC
J Invest Dermatol; 2009 Feb; 129(2):406-14. PubMed ID: 18650848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
